Evidence map›Paper›PMID 42787616›Full record

ArticleHealth affairs scholar2026

Implementing a nicotine cap to make America Healthy Again.

Dana Mowls Carroll, Dorothy K Hatsukami, Olivia A Wackowski, Francis Joseph McClernon, Eric Donny, Mitch Zeller

Abstract read
In one paragraph

Article in Health affairs scholar, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dana Mowls CarrollMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States.ORCID https://orcid.org/0000-0002-4334-9515
Dorothy K HatsukamiMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States.ORCID https://orcid.org/0000-0002-1108-2609
Olivia A WackowskiRutgers Institute for Nicotine & Tobacco Studies, Rutgers University, New Brunswick, NJ 08901, United States.
Francis Joseph McClernonDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC 27710, United States.ORCID https://orcid.org/0000-0002-2846-980X
Eric DonnyDepartment of Translational Neuroscience, Wake Forest University School of Medicine, Winston-Salem, NC 27157, United States.ORCID https://orcid.org/0000-0003-3288-9652
Mitch ZellerCenter for Tobacco Products, Food and Drug Administration, Silver Spring, MD 20993, United States.ORCID https://orcid.org/0009-0002-1461-6028

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The US Department of Health and Human Services' (HHS) "Make America Healthy Again" initiative cannot eradicate the root causes of the nation's chronic disease epidemic without tackling cigarette smoking, which kills over 480 000 Americans and costs $600 billion annually. This commentary reinvigorates a pivotal 2017 FDA framework by urging the current administration to finalize the proposed rule establishing a maximum nicotine cap in all cigarettes and selected combusted tobacco. Evidence demonstrates that capping nicotine at nonaddictive levels (∼95% reduction) rapidly decreases dependence and accelerates smoking cessation. The FDA projects that a nicotine cap will prevent 4.3 million smoking-related deaths by 2100 while saving $1.1 trillion annually in healthcare and productivity costs over 40 years. To maximize these gains, we outline 2 supporting strategies. First, the administration must substantially fund the nation's under-resourced smoking cessation infrastructure to meet the inevitable surge in quitting. Second, provide adults who smoke evidence-based information on the full spectrum of quitting smoking options by communicating the tobacco/nicotine continuum of risk, that is, that combusted products (eg, cigarette) carry the greatest risk of disease, non-combusted products (eg, e-cigarettes) are likely to pose less risk than cigarettes, and medicinal nicotine products (eg, patches) are the safest option.

Indexed as

addictioncancerchronic diseasecigarettescontinuum of riskMAHAmake America healthy againNicotine standardpublic health policyrelative riskssmoking cessationtobaccotobacco control policy

Identifiers

PMID42787616
PMCPMC13602413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.